Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain | 4 | 2016 | 396 | 1.160 |
Why?
|
| Zygapophyseal Joint | 1 | 2020 | 3 | 0.710 |
Why?
|
| Nerve Block | 1 | 2020 | 41 | 0.670 |
Why?
|
| Pain Measurement | 5 | 2022 | 327 | 0.660 |
Why?
|
| Low Back Pain | 1 | 2020 | 108 | 0.650 |
Why?
|
| Spinal Cord | 5 | 2016 | 195 | 0.530 |
Why?
|
| Pain Management | 2 | 2022 | 146 | 0.510 |
Why?
|
| Decision Making | 1 | 2016 | 395 | 0.410 |
Why?
|
| Chronic Pain | 3 | 2022 | 134 | 0.350 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 73 | 0.310 |
Why?
|
| Stroke | 1 | 2016 | 1127 | 0.270 |
Why?
|
| Neurons | 2 | 2013 | 863 | 0.230 |
Why?
|
| Inflammation | 2 | 2013 | 1099 | 0.210 |
Why?
|
| Neuralgia | 2 | 2014 | 20 | 0.200 |
Why?
|
| Posterior Horn Cells | 2 | 2013 | 4 | 0.190 |
Why?
|
| Lumbosacral Region | 1 | 2020 | 16 | 0.180 |
Why?
|
| Anesthetics, Local | 1 | 2020 | 68 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 3231 | 0.150 |
Why?
|
| Analgesics | 2 | 2022 | 96 | 0.150 |
Why?
|
| Nerve Fibers, Unmyelinated | 2 | 2016 | 6 | 0.150 |
Why?
|
| Kainic Acid | 1 | 2016 | 6 | 0.130 |
Why?
|
| Collagenases | 1 | 2016 | 14 | 0.130 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2016 | 7 | 0.130 |
Why?
|
| Hyperalgesia | 1 | 2016 | 12 | 0.130 |
Why?
|
| Lidocaine | 1 | 2016 | 30 | 0.130 |
Why?
|
| Microinjections | 1 | 2016 | 67 | 0.130 |
Why?
|
| Sensation | 1 | 2016 | 19 | 0.130 |
Why?
|
| TRPV Cation Channels | 1 | 2016 | 18 | 0.130 |
Why?
|
| Thalamus | 1 | 2016 | 64 | 0.120 |
Why?
|
| Spinothalamic Tracts | 1 | 2014 | 1 | 0.120 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2014 | 1 | 0.120 |
Why?
|
| Oligodendroglia | 1 | 2014 | 33 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 442 | 0.110 |
Why?
|
| Axons | 1 | 2014 | 118 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 98 | 0.110 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2013 | 13 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2013 | 70 | 0.110 |
Why?
|
| Phenotype | 2 | 2022 | 1137 | 0.100 |
Why?
|
| Animals | 8 | 2016 | 19651 | 0.100 |
Why?
|
| Calcium Signaling | 1 | 2013 | 153 | 0.090 |
Why?
|
| Genomics | 1 | 2013 | 319 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2009 | 1994 | 0.080 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2009 | 11 | 0.080 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2009 | 16 | 0.080 |
Why?
|
| Sphingolipids | 1 | 2009 | 23 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2009 | 63 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2014 | 986 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2009 | 165 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2013 | 608 | 0.080 |
Why?
|
| Sensory Receptor Cells | 1 | 2008 | 17 | 0.080 |
Why?
|
| Nociceptors | 1 | 2008 | 9 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2050 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2014 | 774 | 0.080 |
Why?
|
| Action Potentials | 1 | 2008 | 101 | 0.080 |
Why?
|
| Cell Movement | 1 | 2009 | 429 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 258 | 0.070 |
Why?
|
| Mice | 5 | 2014 | 10292 | 0.070 |
Why?
|
| Gene Expression | 1 | 2009 | 809 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2013 | 574 | 0.060 |
Why?
|
| Humans | 3 | 2022 | 59360 | 0.060 |
Why?
|
| Rats | 3 | 2013 | 1910 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2009 | 2902 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1206 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2093 | 0.030 |
Why?
|
| Nociception | 1 | 2014 | 9 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 247 | 0.030 |
Why?
|
| Astrocytes | 1 | 2014 | 116 | 0.030 |
Why?
|
| Pregabalin | 1 | 2013 | 4 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2013 | 44 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2013 | 230 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 550 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 230 | 0.020 |
Why?
|
| Male | 4 | 2013 | 27739 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 173 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2009 | 258 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2008 | 9 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2008 | 19 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2008 | 10 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2008 | 29 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 366 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2008 | 24 | 0.020 |
Why?
|
| Peripherins | 1 | 2008 | 14 | 0.020 |
Why?
|
| Biophysics | 1 | 2008 | 41 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 126 | 0.020 |
Why?
|
| Imidazoles | 1 | 2008 | 77 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 127 | 0.020 |
Why?
|
| Pyridines | 1 | 2008 | 98 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 806 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 349 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 418 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1504 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 661 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 5284 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 3617 | 0.010 |
Why?
|